New weight-loss drugs, including a class known as GLP-1s, appear to be safe and effective for people living with HIV. These drugs have also been found to have various effects and potential concerns, such as possible links to breast cancer and addiction, and their safety for older adults is being considered. The effectiveness and potential risks of specific weight-loss drugs, including Zepbound, Wegovy, and Ozempic, are being compared and studied.